De novo design of protein competitors for small molecule immunosensing

preprint OA: closed
Full text JSON View at publisher

Abstract

Competition-based immunoassays are a common strategy for detecting small-molecule biomarkers. However, these assays rely on the availability of a custom competitor molecule that can effectively be displaced upon analyte binding, often requiring time-consuming synthesis and conjugation steps. De novo designed protein binders present a compelling alternative, as their binding properties can be tuned and they allow for straightforward genetic-incorporation into existing immunoassays. Here, we leverage the BindCraft pipeline to design competitive binders by targeting antigen-binding sites, followed by in silico filtering to select for steric clashes with the small-molecule analyte. As a proof of concept, we designed digoxin competitors and experimentally screened the binders using a simple bioluminescent assay, identifying 7/10 successful binders directly in bacterial lysate. These binders exhibited low to moderate binding affinities ( K d = 42 nM – 1.1 µM) and were displaced by digoxin. Two de novo binders were encoded into a previously established competition-based immunosensor, enabling sensitive digoxin detection ( K d = 109 nM). These results demonstrate that deep learning-based models can rapidly yield effective competitor binders, enabling straightforward adaptation and optimization of sensing platforms for small-molecule targets.
Full text 1,438 characters · extracted from oa-doi-fallback · click to expand
Abstract Competition-based immunoassays are a common strategy for detecting small-molecule biomarkers. However, these assays rely on the availability of a custom competitor molecule that can effectively be displaced upon analyte binding, often requiring time-consuming synthesis and conjugation steps. De novo designed protein binders present a compelling alternative, as their binding properties can be tuned and they allow for straightforward genetic-incorporation into existing immunoassays. Here, we leverage the BindCraft pipeline to design competitive binders by targeting antigen-binding sites, followed by in silico filtering to select for steric clashes with the small-molecule analyte. As a proof of concept, we designed digoxin competitors and experimentally screened the binders using a simple bioluminescent assay, identifying 7/10 successful binders directly in bacterial lysate. These binders exhibited low to moderate binding affinities (Kd = 42 nM – 1.1 µM) and were displaced by digoxin. Two de novo binders were encoded into a previously established competition-based immunosensor, enabling sensitive digoxin detection (Kd = 109 nM). These results demonstrate that deep learning-based models can rapidly yield effective competitor binders, enabling straightforward adaptation and optimization of sensing platforms for small-molecule targets. Competing Interest Statement The authors have declared no competing interest.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00